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Abstract
Background: Synthetic systems that use positive feedback have been developed to control human disease vectors
and crop pests. The tTAV system, which has been deployed in several insect species, relies on a positive feedback
circuit that can be inhibited via dietary tetracycline. Although insects carrying tTAV fail to survive until adulthood in
the absence of tetracycline, the exact reason for its lethality, as well as the transcriptomic effects of an active positive
feedback circuit, remain unknown.
Results: We engineered the tTAV system in Drosophila melanogaster and investigated the effects of tTAV genome integration
locus on the whole fly transcriptome during larval and adult life stages in four transgenic fly strains using gene expression
microarrays. We found that while there were widespread effects on the transcriptome, the gene expression differences
after removal of tetracycline were not consistent between integration sites. No specific region of the genome was affected,
no common set of genes or pathways, nor did the integration site affect the transcripts in cis.
Conclusion: Although the positive feedback tTAV system is effective at killing insect larvae regardless of where it is inserted
in the genome, it does not exhibit a specific, consistent transcriptional signature. Instead, each insertion site is associated
with broad, but different, transcriptional effects. Our results suggest that lethality may not be caused by a direct effect on
transcription of a set of key genes or pathways. Instead, we propose that rather than a specific action of a tTAV protein, it
is the stochastic transcriptional effects specific to each insertion site that contribute to the tTAV-induced mortality.
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Background
Synthetic gene circuits that rely on positive feedback have
been developed to replace irradiation-based methods for
sterile insect technique (SIT) [1–4]. SIT has been an effect-
ive control strategy for insect populations, for more than
60 years, where sterilized males of a particular species are
released and mate with females from the target population
[5, 6]. It is species-specific, environmentally friendly, and
has been effective at controlling a wide variety of insects.
Molecular techniques can potentially improve the efficiency
and effectiveness of SIT through the development of simple
synthetic gene circuits that confer lethality or allow selec-
tion of only male insects for release [1, 2, 4, 7, 8].
A synthetic system that relies on a positive feedback
gene circuit has been deployed in the mosquito Aedes
aegypti [1, 2, 9–11]. This system, called OXI513a, has
moved beyond field trials and has been used to suppress
targeted mosquito populations [9, 12]. Like all SIT sys-
tems, population suppression is achieved via the release
of OX513a male mosquitoes that mate with local
females to produce no or very few offspring that survive
to adulthood.
The lethality system used in OXI513a relies on the prod-
uct of a single gene, tetracycline-controlled TransActiVator
(tTAV), which enhances its own expression [1–3]. Positive
feedback is generated via basal expression of the tTAV acti-
vator protein, a fusion of the tetracycline-binding domain
(tetR) and the herpes simplex virus transcriptional activator
(VP16) [13]. In the absence of tetracycline, the tetR domain
of the tTAV protein binds to one of several TetO sequences
upstream from the tTAV-encoding region. Each binding of
tTAV further increases its own expression, via its VP16
domain. However, when an organism is provided with
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sufficient dietary tetracycline, which functions as an inhibi-
tor, the tetR domain binds the antibiotic. The feedback is
suppressed and the expression of tTAV remains at the low
levels established by the basal promoter (Fig. 1). The sup-
pression means the dominant lethality is inhibited and the
insects can be produced in large numbers for release.
In the absence of tetracycline, activation of the tTAV
positive feedback system kills insects before they become
reproductive, making this an effective control system in a
post-release environment. However, unlike other genetic
tTAV based systems that rely on control of gene expres-
sion induced lethality [4, 7, 14, 15], the exact reason for le-
thality of the positive feedback system remains unknown.
Proposed mechanisms include tTAV toxicity, change in
expression of critical transcripts, transcriptional squelch-
ing, wherein localised transcriptional machinery is titrated
away, or overloading of the ubiquitin protease pathway
due to high protein production [1, 3]. Complicating the
understanding of this phenomenon is a very limited know-
ledge on the effects of synthetic positive feedback circuits
on an organism’s transcriptome.
The tTAV system has been introduced into several insect
species, but in some insertion sites the tTAV system is
recessive lethal, even when not active, and therefore cannot
be homozygous. A strain homozygous for the tTAV system
was reported in A. aegypti and Ceratitis capitata (medfly)
but not D. melanogaster [1, 3]. Moreover, a similar tTAV
system that included an intron and multiple tTAV encoding
regions, when introduced into Pectinophora gossypiella
(pink bollworm) was predominantly recessive lethal, com-
plicating the generation of a homozygous line [16].
The tTAV positive feedback systems function as expected
in each insect species tested, in that tTAV expression is
repressible with dietary tetracycline and lethal without it.
However, the timing of lethality varied among species and
even between insertion sites within the same species. In P.
gossypiella, death reportedly occurred in the larval stage
[16]. Whereas, of the three A. aegypti lines that displayed
tetracycline repressible dominant lethality, two died in
early larval stages, and the third died during the transition
from late larvae to early pupae [2]. This insertion site-
specific variation in the lethality timing was also noted in
C. capitata [3].
Compared to animals grown on dietary tetracycline,
tTAV expression is enhanced 36-fold in C. capitata third
instar larvae and 48-fold in adults deprived of tetracycline
for 4 days [3]. A. aegypti adults removed from 100 μg/mL
tetracycline had a 150-fold increase tTAV expression after
4 days [1]. Finally, D. melanogaster adults had 46-fold and
69-fold increases after 1 and 4 days, respectively, after
deprivation of 100 μg/mL tetracycline [1]. This highlights
the responsiveness of the tTAV system, showing that the
suppressive effect of residual tetracycline is quickly over-
come. In each of these three species no impact on adult
lifespan or health could be detected after removal of diet-
ary tetracycline [1, 3]. Also, when adult mice carrying a
tTAV-based system were no longer provided dietary tetra-
cycline they lived for six months without observable ill
effects [17]. It was proposed that this lack of lethality in
adults may reflect transcriptional squelching or that inter-
ruptions to ubiquitin-dependent protein degradation may
be less harmful to adults [3]. It may also be that the tTAV
feedback circuit elicits a diminished response, at the tran-
scriptomic level, in adults.
Understanding what factors contribute to the variance
in tTAV-associated mortality is likely to inform the devel-
opment of insect control systems. In the present study,
the OXI513a tTAV feedback circuit was introduced and
cb
a
Fig. 1 The TransActiVator (tTAV) feedback circuit. a Schematic of the tTAV system. b In the absence of tetracycline, basal levels of tTAV protein
bind its own promoter at the TetO sites, thereby increasing tTAV protein production. This new protein binds the promoter and further increases
expression. c In the presence of tetracycline, low levels of tTAV are sequestered and expression of tTAV mRNA remains at basal levels
Bryk et al. BMC Genomics  (2017) 18:990 Page 2 of 14
verified into D. melanogaster [1]. The tight tetracycline
regulation of the system affords a convenient method to
conduct a strain-by-strain assessment of the tTAV system
and determine the transcriptomic effect, if any, of a posi-
tive feedback circuit. Transcriptomic analysis of four inde-
pendent D. melanogaster tTAV insertion lines, in both
adults and larvae, was conducted to examine the tran-
scriptomic influence of the tTAV system.
Results
The tTAV lethality system in D. melanogaster
A tTAV positive feedback circuit, based on the LA513 plas-
mid, used in the development of A. aegypti OXI513a, [1],
was developed for use in D. melanogaster. Using PhiC31
landing sites the above plasmid was integrated at specific
widely used locations throughout the D. melanogaster gen-
ome (Table 1 and Methods). These landing sites represent
a range of genomic locations that include each of the D.
melanogaster chromosomes except the Y. Moreover, the
chosen strains contain very well characterised homozygous
landing sites. The tTAV heterozygous (technically hemizy-
gous, but the term heterozygous is used here for conveni-
ence) stocks contained balancer chromosomes and, although
viable when provided dietary tetracycline, failed to produce
adult transgenic offspring in the absence of tetracycline.
Lethality usually occurred prior to the third instar stage of
larval development. Specifically, the onset of the lethality
phenotype commenced part way through the second instar.
Generally, all larvae would die prior the third instar but
very rarely single third instar larvae would crawl up the
side of control vials; none of these individuals would pu-
pate prior to dying. Unlike tTAV in other organisms, not
obvious difference in lethality timing between insertion
sites was detected. As in previous tTAV systems, adults
could be deprived of tetracycline without any observed ill
effects. Of 10 integration loci tested, nine strains failed to
produce homozygous offspring when raised on 100 μg/mL
dietary tetracycline. Only cytological position 102D was
viable as a homozygote. Increasing dietary tetracycline dos-
age to 200 μg/mL did not permit tTAV homozygosity or
the establishment of a strain containing two tTAV integra-
tions at both, adjacent, cytological positions 51C and 51D.
However, crosses with 100 μg/mL dietary tetracycline
between strains containing the tTAV integration at position
51C, on the second chromosome, and 76A2 or 86Fb, on
the third chromosome, produced offspring containing both
two tTAV integrations. Furthermore, an insertion at locus
19E7, on the X chromosome, produced viable male flies.
To ensure that the tTAV circuit behaved consistently,
with respect to the previous systems, a series of survival
tests were conducted. A two-generation crossing regime
was used, wherein tTAV-102D males were crossed with
‘white eyed’ (w1118) females, and their offspring were back-
crossed to the same w1118 line (Table 6 and Methods).
Dietary concentrations of tetracycline, doxycycline,
oxytetracycline, or chlorotetracycline varying over five
orders of magnitude (0.01 to 100 μg/mL) were tested for
their ability to rescue tTAV-102D in the aforementioned
two-generation cross (Fig. 2a). Survival shows a clear
response to dietary tetracycline concentration, with doxy-
cycline capable of rescuing tTAV system lethality at a con-
centration almost an order of magnitude lower than other
tetracycline homologs.
Both tetracycline- and doxycycline-induced survival
had a similar, almost logarithmic dose response, despite
the 10× difference in dosage. A more exact determination
of the rescue threshold for tetracycline and doxycycline
was obtained by repeating the above experiment with in-
creased tetracycline dosage resolution (Fig. 2b). Tetracycline
demonstrated a sharp decline in its capacity to rescue tTAV
lethality between 5 μg/mL and 1 μg/mL whereas doxycycline
demonstrated a similarity sharp decline between 0.4 μg/mL
and 0.1 μg/mL.
Microarray analyses
To investigate the influence of the tTAV feedback circuit on
gene activity, we assessed the changes in the transcriptome
with and without tetracycline. This system provides an ideal
internal control when examining flies raised with versus
without tetracycline, as it allows us to differentiate transcrip-
tional effects of the tTAV system in different genetic back-
grounds and life stages (see Fig. 6 for the experimental
design). We initially examined the transcriptional effects with
and without tetracycline in a homozygous strain 102D–tTAV,
but as we were unable to generate additional viable homozy-
gous strains, we subsequently analysed three additional
chromosome-balanced heterozygous tTAV strains. We also
analysed a non-tTAV line. In each of the lines, we analysed
two life stages, adults and second instar larvae, every time
Table 1 Details of tTAV stocks, insertion sites and viability. Viability is
the ability to survive when grown on media containing 100 μg/mL
tetracycline. The tTAV hemizygous stocks contained balancer
chromosomes. All tTAV flies die in the absence of tetracycline
Chromosome –
Cytological Site
Viability
X – 19E7 Hemizygous Viable / Male Viable / Homozygous Lethal
2 L – 22A Hemizygous Viable / Homozygous Lethal
2 L – 28E7 Hemizygous Viable / Homozygous Lethal
2R – 43A1 Hemizygous Viable / Homozygous Lethal
2R – 51C Hemizygous Viable / Homozygous Lethal
2R – 51D Hemizygous Viable / Homozygous Lethal
3 L – 68E Hemizygous Viable / Homozygous Lethal
3 L – 76A2 Hemizygous Viable / Homozygous Lethal
3R – 86Fb Hemizygous Viable / Homozygous Lethal
4 – 102D Hemizygous Viable / Homozygous Viable
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comparing gene activity with versus without tetracycline for
each strain and life stage (Table 2). Due to the use of balan-
cer chromosomes, wherein balancer homozygotes die as
embryos, and the tTAV recessive lethality at these loci, the
genotype of all offspring is known without the need for
phenotypic selection.
Expressed genes are shared among strains and within
developmental stages
Overall, 10,950 genes were expressed in adults and 9947
in larvae, across all strains and treatments (Methods).
Most expressed genes were shared among all strains in
each developmental stage: 9554 genes of the 10,950
expressed in adults (87%) were expressed in all adult
strains and treatments and 7784 of 9947 genes expressed
in larvae (81%) were shared among all larvae strains and
treatments (Table 3 and Fig. 3).
Differentially expressed genes are not shared among
different tTAV strains
We next analysed differential gene expression with and
without tetracycline within each strain and developmental
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Fig. 2 Characteristics of the tTAV circuit. The crossing scheme and media used are described in detail in the Methods, but, briefly, the homozygous 102D–tTAV
line was crossed to a ‘white eyed’ w1118 line. Red-eyed wildtype flies, indicating the presence of the tTAV-system, were back crossed to the w1118 line and the
percentage of tTAV flies in the F2 generation on various types and concentrations of antibiotic media was determined. Due to the use of tTAV heterozygotes,
50% survival represents the maximum percentage of the offspring that can inherit tTAV. Each data point is the median of 10 replicates. The data are presented
as a standard boxplot with whiskers extending to the lowest or highest value within 1.5 times the IQR from the hinge. a Median survivorship for 4 members of
the tetracycline class of antibiotics across dosages spanning 5 orders of magnitude. b Higher dosage resolution of median survivability for tetracycline
and doxycycline, showing critical thresholds for antibiotic rescue. The IC50 values for doxycycline and tetracycline are 0.161 and 3.338, respectively
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stage. We performed a moderated t-test for differential
gene expression and set the false discovery rate (FDR) at
10% to identify differentially expressed genes (Methods).
At this cut-off, there were no genes differentially
expressed due to dietary tetracycline in either larvae or
adults in the non-tTAV control. Homozygous 102D–
tTAV adults, however, stood out, with 2301 differentially
expressed genes compared to 0, 1, and 3 in heterozygous
adult tTAV strains. In contrast, in larvae, heterozygous
strain 76A2-tTAV had 2116 differentially expressed
genes compared to 115, 311, and 336 in the other larval
strains (Table 4).
Crucially, we detected little overlap in differentially
expressed genes with vs. without tetracycline in any trans-
genic strains or life stages. Among adult tTAV flies, there
were no shared differentially expressed genes. Among
tTAV larvae, however, there were 31 differentially
expressed genes common to all strains (Fig. 4).
When we investigated these 31 genes more closely, we
found that 27 of them had opposite directions of expres-
sion change depending on the strain (in some strains a
gene had higher expression without tetracycline and in
other strains expression was higher with it). Only four
genes showed a consistent pattern of expression change
across all transgenic larval strains: crok (CG17218,
FBgn0032421) had higher expression with tetracycline
(i.e with tTAV system off ), whereas Cyp6a17 (CG10241,
FBgn0015714), olf186-F (CG11430, FBgn0041585), and
Pex23 (CG32226, FBgn0052226) had higher expression
without tetracycline (i.e. with tTAV system on). However,
while these differences were statistically significant, they
were very small: the range of fold changes in expression
level with vs. without tetracycline in all larvae strains
was between 0.72 and 1.74. Table 5 shows fold changes
of expression levels and adjusted p-values for each of the
four genes.
Differentially expressed genes in different strains do not
belong to the same functional categories
We next investigated whether differentially expressed genes
in each line and developmental stage were over-represented
in similar functional categories. We observed very little over-
lap between compared groups, with gene ontology (GO) cat-
egories of fatty acid metabolism (GO:0006631, GO:0006635
and GO:0009062), C-acyltransferase activity (GO:0016408),
protein deubiquitination (GO:0016579) and cellular lipid
catabolic processes (GO:0044242) occurring in larvae 102D–
tTAV and 51D–tTAV and mitochondrial part (GO:0044429)
being common to 102D–tTAV adults and 76A2-tTAV larvae
(Additional File 1: Table S1). We also analysed GO categories
for the 31 genes that were differentially expressed in all four
transgenic larvae strains. Among 14 categories found, three
were related to ubiquitin-specific protease (GO:0004843) and
to ubiquitinyl hydrolase activity (GO:0036459 and
GO:0101005) (Additional File 2: Table S2).
Differences in gene expression are not correlated
between strains
Given the limited consistency in the response to tetracycline
treatment in various strains, we checked whether the gene
expression differences with vs. without tetracycline in each
strain might be correlated. Such correlation would indicate a
consistent change in gene expression levels across many
genes in each strain, irrespective of the significance of a
small number of individual genes. We calculated all pairwise
Pearson’s correlation coefficients of differences between
expression levels with versus without tetracycline in each
strain. We found that while all genome-wide correlations
were statistically significant, including correlations with the
non-tTAV strain (the largest p < 2 × 10−5), the sign of the
correlation varied (Fig. 5).
tTAV genomic insertion locus does not affect
transcription of nearby genes
Given that we observed virtually no shared differentially
expressed genes, no consistent functional categories of dif-
ferentially expressed genes, nor correlations of gene expres-
sion differences with versus without tetracycline in different
lines and life stages (Figs. 3, 4 and 5), we investigated
whether the physical location of the transgene could explain
Table 2 Fly Stocks used for Microarray
Strain ID Genotype Bloomington ID Genome Integration
non-tTAV y1; Gr22biso-1 Gr22diso-1 cn1 CG33964iso-1 bw1 sp1; LysCiso-1 MstProxiso-1 GstD5iso-1 Rh61 2057
51D–tTAV y1 M{vas-int.Dm}ZH-2A wa; M{3xP3-RFP.attP, w[+mc], tTAV}ZH-51D/CyO 24483a Dmel_2R-15,054,298
76A2 - tTAV y1 w1118; PBac{y + -attP-9A, w[+mc], tTAV}VK00013/TM1 9732a Dmel_3L-19,204,358
86F - tTAV y1 M{vas-int.Dm}ZH-2A wa; M{3xP3-RFP.attP, w[+mc], tTAV}ZH-86Fb/TM1 24749a Dmel_3R-11,808,607
102D - tTAV y1 M{vas-int.Dm}ZH-2A wa; M{3xP3-RFP.attP, w[+mc], tTAV}ZH-102D 24488a Dmel_4–988,349
adenotes progenitor strain ID
Table 3 Number of expressed genes in each strain and stage
non-tTAV 102D–tTAV 76A2-tTAV 86F–tTAV 51D–tTAV
Adult Flies 10,844 9986 10,784 10,831 10,575
Larval Flies 8881 9536 8715 8875 8720
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these observations. As each of the strains had tTAV inserted
in a different genomic location, tTAV transgene affecting
genes in its physical proximity could be responsible for the
observed pattern.
We tested for such cis-acting effects by analysing the dis-
tribution of differentially expressed genes in the genome
with a sliding window approach. We constructed overlap-
ping gene windows containing 10 genes each and overlap-
ping a neighbouring window by 9 genes, thus ensuring
single-gene resolution of the potential effects. We then
counted windows in which the proportion of differentially
expressed genes was above an arbitrarily chosen threshold
of 30%. We observed no clear relationship between the in-
sertion loci and location of differentially expressed genes.
There were no windows with more than 3 differentially
expressed genes in any strain or life stage, except in 102D–
tTAV adults and 76A2-tTAV larvae, where 202 (out of
9529, 2%) and 387 (out of 7764, 5%) windows, respectively,
showed more than 3 differentially expressed genes, consist-
ent with the very large number of differentially expressed
genes in these strains and life stages (Additional File 3: Fig-
ure S3 and Fig. 4).
To test whether the observed distribution of windows
was statistically significant, we performed a permutation
test, in which we randomly placed the genes along each
chromosome or chromosome arm and re-calculated the
number of windows in which the proportion of differen-
tially expressed genes was above 30%, for 10,000 itera-
tions. The only significant value we observed for these
comparisons was for chromosome 2 L in larval strain
76A2-tTAV (p = 0.0338), potentially indicating that the
distribution of 10-gene windows with more than 3 dif-
ferentially expressed genes on chromosome 2 L in this
strain and developmental stage was non-random. We
note, however, that in this strain the transgene is located
on chromosome 2R.
Discussion
Use of increasingly complex gene circuits for biotechnol-
ogy and research applications necessitates understanding
their influences on the systems in which they are placed.
To this end, development of any genetic circuit, such as
the tTAV system, in a well-characterized multicellular
model organism like D. melanogaster, allows assessment
of transcriptomic perturbations.
Although we detected insertion site variation, we found
no large differences between insertion sites in timing of
Fig. 3 Number of shared expressed genes in all strains for adult and larval flies. Bar height represents the number of expressed genes and the
black dots below indicate to which of the lines the genes belong. Sets with fewer than 10 genes are not shown. In both stages most of the
genes are expressed in all five lines
Table 4 Number of differentially expressed genes in each strain
and life stage at FDR = 10%
non-tTAV 102D–tTAV 76A2-tTAV 86F–tTAV 51D–tTAV
Adult Flies 0 2301 0 3 1
Larval Flies 0 311 2116 115 336
Bryk et al. BMC Genomics  (2017) 18:990 Page 6 of 14
lethality, unlike those described in the A. aegypti or C.
capitata [1–3]. A possible explanation for the reduced in-
sertion site variation is that tTAV systems employ a D.
melanogaster basal promoter. Although the use of heterol-
ogous promoters is routine, particularly in non-model
organism transgenic work, significant genomic differences
exist due to the large evolutionary distance between D.
melanogaster and A. aegypti [18–20]. These differences
may lead to less predictable transcription behaviour.
The tTAV system reported here responds to tetracyc-
line analogues in a dose-dependent fashion (Fig. 2a & b)
and doxycycline rescues tTAV lethality at a concentra-
tion almost 10 times lower than tetracycline (Fig. 2b).
These results are very similar to those from other sys-
tems [4, 21], as expected given the behaviour of doxycyc-
line in commercial TET systems, such as the Clontech
TET-On system. The integration-site-specific recessive
lethality of the tTAV system, even when inactivated via
dietary tetracycline, coupled with the viable males with
X chromosome integration and the viability of double
heterozygotes, suggests an interaction more complex
than simple dosage of the tTAV protein. Moreover, as
double heterozygotes of close insertion sites, 51C and
51D, were also non-viable, a possible explanation is that
the tTAV system is subject to transvection effects on
gene expression [22]. However, extensive further testing,
such as placing the tTAV promoter region and the cod-
ing region on separate chromosomes, would need to be
conducted to confirm this. The timing of lethality to late
larvae/early pupae implies disruptions of imaginal disc
development [23, 24] or neurogenesis and behaviour
[25]. Further elucidation of mechanisms involved in site-
specific transcriptional effects might be achieved by
quantifying tissue specificities of changes in gene expres-
sion in response to positive feedback (e.g., imaginal disc
versus mushroom bodies).
Fig. 4 Number of shared differentially expressed genes in all transgenic strains for adult and larval flies. Bar heights represents the number of
differentially expressed genes and black dots below indicate to which of lines genes belong. In both stages most of the differentially expressed
genes are only present in a single line
Table 5 Shared differentially expressed genes show very small
differences with versus without tetracycline. Fold change of
expression levels and adjusted p-values for each of the four genes
that showed consistent expression level change with versus without
tetracycline in each transgenic larvae strains. Fold change is higher
than 1 if expression increased off of tetracycline
Crok Cyp6a17 olf186-F Pex23
102D–tTAV
Fold Change 0.81 1.34 1.10 1.03
adj p-value 0.05 0.05 0.03 0.02
76A2-tTAV
Fold Change 0.97 1.33 1.05 1.24
adj p-value 0.01 0.01 0.01 <0.01
86F–tTAV
Fold Change 0.72 1.03 1.18 1.05
adj p-value 0.08 0.08 0.05 0.02
51D–tTAV
Fold Change 0.91 1.74 1.14 1.04
adj p-value 0.03 0.04 0.01 <0.01
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To assess the impact of the tTAV system on the transcrip-
tome, and to determine the cause of lethality, we mediated
the activity of the tTAV system with dietary tetracycline and
compared gene expression between on and off states.
Although each of the conditions and strains tested had a
similar number of expressed genes (Table 3 and Fig. 3), we
identified 1–3 orders of magnitude difference between the
numbers differentially expressed genes in larvae versus those
in the adults of the same line (Table 4 and Fig. 4).
In the non-tTAV strain, we failed to detect any differ-
entially expressed genes with a 10% FDR (Table 4). This
is surprising, as several authors have reported that in D.
melanogaster tetracycline disrupts mitochondrial func-
tion and leads to trans-generational effects [26, 27]. It
has been shown that tetracycline can disrupt mitochon-
drial protein translation [28], which results in mitonuc-
lear protein imbalance and inhibition of respiration [29].
Respiration inhibition in HEK293 cells disappeared after
removal of doxycycline [29]. In addition, RT112 cells
exposed to doxycycline were found to differentially
express 9.5% of all expressed genes [29]. These findings,
and numerous others, illustrate the need for caution in
drawing biological conclusions when tetracycline is used
for research purposes [30]. However, unlike the present
study, many D. melanogaster studies did not subject
their fly lines to several generations of growth on tetra-
cycline prior to with-versus-without tetracycline experi-
ments. It is possible that by this process we are
removing much of the tetracycline-induced variability by
selective killing of the D. melanogaster microbiota [28],
or via mitochondrial damage that takes time to return to
normal. Regardless of the reason for this muted response
to tetracycline, it appears that any differential expression
in our experiments is the result of tTAV activation and
not to the use of tetracycline.
By examining genes that are differentially expressed in
each insertion line, there may be the expectation that the
lethal tTAV phenotype is due to change in expression of
critical genes shared between the lines, or that a synthetic
positive feedback loop has a standard transcriptional
response. However, only larval samples showed genes that
were differentially expressed for all insertion sites. Of the
31 differentially expressed genes only four had the same
direction of differential expression and the fold change
was, generally, extremely low (Table 5). In addition,
regression analysis of differentially expressed genes in each
strain found that all correlations were significant, but var-
ied in direction (Fig. 5). It appears that not only does the
insertion of tTAV have a limited effect on the transcrip-
tome, but also any effect it does have is insertion site-
specific with little overlap between sites.
It is possible that the four genes with similar differential
expression in larval samples represent a group of core
genes responsible for lethality. Two of these, crok and
olf186-F, result in recessive lethality when mutated. At first
glance, it might seem reasonable that tTAV lethality could
be related to changes in expression of these genes, but this
does not appear to be true. Although the differential
expression is in the same direction for each of the four
genes, the magnitudes of the changes are modest, and
Fig. 5 Genome-wide correlations between differences in expression levels with versus without tetracycline for each pair of tTAV larval strains. r is
Pearson’s correlation coefficient. All correlations are statistically significant with the largest, p < 2 × 10–5
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they differ between insertion lines (Table 5). Both reces-
sive p-element insertions and RNAi knockdowns exist for
crok and olf186-F, and both produce lethality as late as the
pupa stage [31, 32]. This is in contrast to larval lethality
seen in second to third instar stages for each tTAV line.
This variation in phenotype and high variability in expres-
sion between insertion sites means crok and olf186-F do
not offer a simple explanation for D. melanogaster lethality.
Another possible reason for tTAV lethality is that the
feedback circuit overloads translational or protein catab-
olism machinery, but our data did not support this
conclusion. We searched for previously identified tran-
scriptional markers of translational stress to determine
whether this is a viable hypothesis [33]. We checked
whether Xbp1 (FBgn0021872), crc (FBgn0000370),
CG7140 (FBgn0037147), CalX (FBgn0013995), MGST1
(FBgn0025814), CBS (FBgn0031148) and KrT95D
(FBgn0020647) are among the differentially expressed
genes in any of our strains or developmental stages at FDR
= 10%. We only detected differential expression of crc,
MGST1 and CG7140 in the adult 102D–tTAV strain; crc
was also present in larval 102D–tTAV, 76A2-tTAV and
51D–tTAV, whileMGST1 was present in larval 76A2-tTAV.
Cellular stresses are known to trigger specific pathway re-
sponses and by analysing differentially expressed pathways
we sought to capture transcriptome responses shared across
all insertion lines that might have been missed in single gene
analyses. However, once again, our data did not reveal a
clear set of cellular processes represented in all cell types.
When GO analysis was performed on the 31 genes differen-
tially expressed in all larval tTAV samples, ubiquitin prote-
ase/hydrolase categories were over-represented. Another
hypothesis for tTAV lethality is that the circuit overloads the
ubiquitin-tagged proteolysis pathway [1] and while the above
observation might have been indicative of that, once again,
it is unlikely to be the case. As mentioned above, only four
of the 31 genes shared the same direction of differential
expression, whereas one might have expected a general up-
regulation of these pathways in response to overproduction
of tTAV protein.
We also explored the hypothesis that activation of the
tTAV circuit influences expression in specific genomic
regions, either haphazardly or physically near the insertion
site, but no evidence of a response was detected.
Although the tTAV system alters gene expression, depend-
ing on the integration site, there were no obvious localized
effects of the integration. One might assume that the pres-
ence of a regulatory region with several activators bound, as
is the case with an active tTAV, would potentially influence
expression of neighbouring genes. However, after examining
gene expression around integration sites we found no
evidence of localised tTAV-induced differential expression.
Finally, tTAV protein may be toxic due to the behav-
iour of either the tetracycline-binding domain, tetR, or
the activator domain, VP16. Early in vitro work on a
fusion between the DNA binding domain of yeast GAL4
protein and VP16 demonstrated that this construct inhib-
ited transcription of promoters lacking GAL4-binding
domains [34–36]. In vivo work in Saccharomyces cerevi-
siae showed a link between transcriptional squelching of a
reporter construct and dosage of VP16 [37]. This work
also demonstrated that in addition to activation activity,
VP16, the DNA-binding domain of the fusion protein was
required for squelching. To check for a squelching pheno-
type, we examined differentially expressed genes for a general
tendency toward down-regulation when the tTAV system
was active. However we failed to detect a clear pattern of
squelching, which strongly suggests that this squelching
behaviour is likely not the cause of tTAV lethality.
Although we didn’t detect transcriptional depression,
there could potentially be other mechanisms, or else our
system is not sensitive enough to detect transient squelch-
ing. Several versions of VP16 have been developed that
reduce activity and are tolerated at higher levels in HELA
cells [38]. Additional study of these modified VP16 ele-
ments in our D. melanogaster system could further dissect
potential squelching. Finally, it may also be worth investi-
gating the behaviour of these modified VP16 elements in
insect control systems that do not rely on tTAV positive
feedback [7, 14, 15].
There are several reasons why it is difficult to categor-
ically refute the proposed mechanisms of tTAV lethality.
Our time point late in the second instar may fail to cap-
ture the precise event leading to death. Also it may be
that lethality occurs due to a translational level event or
is due to post-translational modification; hence our tran-
scriptome analysis would miss these events. It may also
be that lethality is related to highly tissue-specific
expression. However, it is clear that tTAV activation has
a large impact on the transcriptome and that this impact
is specific to the tTAV genome integration locus. Given
that there is very little overlap between the transcript
profiles of each integration site and that there is no evi-
dence for alternative explanations, we suggest that tTAV
lethality is the result of integration site-based stochastic
differential gene expression, perhaps due to tissue-specific
expression patterns. Next, temporal and spatial expression
patterns can be explored using specific promoters, such as
those relating to the UAS/GAL4 system and alternative
feedback systems. This will further illuminate the basis of
tTAV lethality and will characterize cellular effects of tran-
scriptional positive feedback.
Conclusion
Although variation due to genome insertion position is a
well-characterised phenomenon, discussion has tended to
focus on expression variability of the inserted construct
and not on the entire transcriptome. This can be further
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complicated when the inserted construct is a circuit that
can be activated. Here we show that the tTAV system,
when activated, influences the whole transcriptome but
that these expressions differences are unpredictable. Spe-
cifically, there was very little overlap in expression
between any of the insertion sites. Furthermore, there was
no discernible pattern in the types of transcripts affected,
as assessed with GO analysis, nor were there any common
genomic regions affected. Finally, expression differences
within each strain did not appear to be localised to the
insertion site. Our data suggest that the hypothesis that
the lethality is caused by a direct effect on transcription of
a set of key genes or pathways may be incorrect. Rather
than a specific action of a tTAV protein, it is the stochastic
transcriptional effects specific to each insertion site that
contribute to the tTAV-induced mortality.
It is imperative to develop and characterize disease vector
and crop pest control systems that are effective, targeted,
consistent and cost-effective. Identifying transcriptomic
underpinnings of cryptic lethality phenotypes can improve
and refine the technology, helping it to gain public trust
[39]. In addition, regulated systems, like tTAV, provide
researchers with powerful tools to distinguish cis and trans
effects in gene regulation at the whole transcriptome level.
Methods
Development of transformation plasmid
The tTAV system was synthesised using DNA 2.0, based
on descriptions of the RIDL system [1–3]. This fragment
was subsequently cloned into the multiple cloning site
of pattB [40] and verified by sequencing. The full se-
quence of the plasmid is provided at doi.org/10.6084/
m9.figshare.5700958.v1.
Fly strains
Strains of flies used in experiments described here can
be found in Table 6. Transgenic flies were created by
injection of the tTAV construct into previously described
docking lines that represented a cross section of the D.
melanogaster genome [40, 41]. Importantly, with respect
to the difficulties of obtaining tTAV homozygous lines,
the docking lines previously described are all homozy-
gous viable. Potential transformants are screened for red
eyes indicating complementation of the w1118 from the
w+mc marker present on the tTAV construct. All fly
injections and transformant screening was performed by
BestGene, Chino Hills, USA.
Fly rearing and media
Flies were incubated on standard Bloomington media at
24 °C under a 14 h light / 10 h dark cycle in either 50 mL
vials or 300 mL bottles. Tetracycline media for stock main-
tenance was made by adding an appropriate volume of
100 mg/mL of tetracycline suspended in 99% ethanol to the
surface of solid prepared food.
For survival tests, tetracycline media was made by
adding an appropriate amount of antibiotic to achieve a
final concentration of 100, 10 or 1 μg/mL and by diluting
with unsupplemented media to the required concentration.
For microarray experiments, TET-On media was made by
adding tetracycline to a final concentration of 100 μg/mL to
cooled (>65 °C) media. Approximately 10 mL of this was
added to 50 mL vials. TET-Off media was the same batch of
food prior being supplemented with tetracycline.
tTAV survival tests
The tTAV circuit contains the red eye marker, w+mc, which
allows it to be tracked when crossed with white eyed, w1118,
virgins. A two-generation crossing system was used in all
survival experiments. To aid collection of virgin females, a
wild stock (‘Plön’) was crossed to ‘Y-hid’, which allows kill-
ing of male larvae via incubation at 37 °C for 30 min. Since
tTAV is marked with a functional copy of the white gene,
conferring red eyes, all individuals in the first generation
were red-eyed and contained one copy of the tTAV circuit.
Three males from this first generation were then back-
crossed to 15 females from the ‘White Eyed’ line in 50-mL
vials. This particular crossing regime was employed such
that the second generation contained 50% tTAV / wild flies;
thus, even when conditions did not permit survival of many
tTAV flies, there were enough individuals to permit survival
of the vial. Parental flies were removed after 5 days. Starting
the day after the first offspring emerged, they were counted.
Survivability is determined by counting both red- and
white-eyed flies, adding these totals for each vial, and divid-
ing the red-eyed files by the total. Each data point was
derived from 10 biological replicates, but vials that failed
produce any flies were removed from the analysis. Plots in
Fig. 2 were made with ggplot2 [42].
Microarray flies and RNA extraction
The tTAV lines and non-tTAV control were maintained
on TET-on media for 5 generations prior to commen-
cing. Thirty flies, 15 male and 15 female, of the same
age, from each of the strains in Table 2, were transferred
to either TET-On or TET-Off media. Five days after
transfer, adult flies were removed and 10 adult flies, 5
male & 5 female, were frozen at −80 °C. Ten larvae from
each of these matings were collected at the late second
instar stage, the last life stage normally seen prior to
lethality, and frozen at −80 °C. Three biological repli-
cates were produced for each combination of strain, life-
stage, and media. RNA was prepared from frozen
samples using Trizol and DNAse was treated using a
PureLink RNA Mini Kit (Invitrogen).
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Generating microarray data
Microarray experiments employed Agilent Drosophila
Gene Expression Microarrays 4x44K and were scanned
on an Agilent G2505C scanner (Agilent Technologies).
Data collection was divided into two separate experiments.
A pilot experiment for strain 102D consisting of two life
stages in two conditions each with three biological repli-
cates – a total of 12 samples. The remaining four strains
were run as a separate experiment with a total of 48 sam-
ples. For each experiment, sample chip position was ran-
domized to avoid genotype- and treatment-specific batch
effects. Fig. 6 schematically shows the experimental design.
Normalisation of microarray data
Microarray data were normalized using the limma pack-
age [43] in R [44]. Specifically, the microarray background
was corrected using the limma normexp function and data
were normalized with limma quantile separately for each
life stage. Following normalization, low intensity and con-
trol probes were removed as per the limma user guide
(rev. 9 June 2015). Low intensity was defined as having at
least 10% lower intensity than the 95th percentile of nega-
tive control probes on at least 3 arrays in each stage. The
principal component analysis (stats package in R) was
used to check for unusual groupings of samples that could
indicate confounding effects and relative log expression
analysis was used to check for sample outliers with regard to
expression level distribution [45] (Additional File 4: Figure S1
and Additional file 5: Figure S2).
Annotation of microarray data
Probes were annotated using MEGABLAST [46]. All
probe names and sequences were extracted from the
array, and a total of 32,162 unique probes were used as
input in a local MEGABLAST (ver. 2.2.31+) against the
Ensembl Drosophila cDNA database of all known and
predicted genes (downloaded on 15th January 2016).
MEGABLAST settings used were:
blastn -task megablast -db db.fa -query
query.txt -dust no -max_target_seqs 1
-outfmt “6 qseqid sseqid evalue pident
stitle”.
Hits with 100% sequence identity, 92.3% of all 26,665
unique hits, and an e-value ≤1e-20 were retained (total
23,752) and Ensembl Gene IDs were extracted from the
retained hit description field. Positional information for
each gene was obtained using the BioMart database with
the R package biomaRt [47]. Comparisons between our
annotation and that of the manufacturer revealed that
there were 5108 (22%) “mismatched” probes in our set.
However, when we compared the overlap of probes after
normalization and low intensity filtering, the “mismatched”
probe fraction was reduced to at most 12%, indicating that
almost half of the probes removed during filtering were
those for which the manufacturer’s annotation differed
from ours.
All further analyses were done on our set of MEGA-
BLAST–annotated probes. After normalization and low
intensity filtering, each sample was filtered to contain only
probes present in our set.
Table 6 Fly stocks used
Strain ID Genotype Origin
19E7-tTAV y1 w1118 PBac{y + -attP-9A, tTAV}VK00006 Bloomington DSC line 9726 injected with tTAV construct
22A–tTAV y1 M{vas-int.Dm}ZH-2A w*; M{3xP3-RFP.attP,
tTAV}ZH-22A
Bloomington DSC line 24,481 injected with tTAV construct
28E7-tTAV y1 w1118; PBac{y+-attP-3B, tTAV}VK00002 Bloomington DSC line 9723 injected with tTAV construct
43A1-tTAV y1 w1118; PBac{y+-attP-9A, tTAV}VK00014 Bloomington DSC line 9733 injected with tTAV construct
51C–tTAV y1 M{vas-int.Dm}ZH-2A w*; M{3xP3-RFP.attP,
tTAV}ZH-51C
Bloomington DSC line 24,482 injected with tTAV construct
51D–tTAV y1 M{vas-int.Dm}ZH-2A w*; M{3xP3-RFP.attP, w+mc,
tTAV}ZH-51D/CyO
Bloomginton DSC line 24,483 injected with tTAV construct
68E–tTAV y1 M{vas-int.Dm}ZH-2A w*; M{3xP3-RFP.attP,
tTAV}ZH-68E
Bloomington DSC line 24,485 injected with tTAV construct
76A2-tTAV y1 w1118; PBac{y+-attP-9A, w[+mc], tTAV}VK00013/TM1 Bloomington line 9732 injected with tTAV construct
86Fb-tTAV y1 M{vas-int.Dm}ZH-2A w*; M{3xP3-RFP.attP, w+mc,
tTAV}ZH-86Fb/TM1
Bloomington DSC line 24,749 injected with tTAV construct
102D–tTAV y1 M{vas-int.Dm}ZH-2A w*; M{3xP3-RFP.attP, w+mc,
tTAV}ZH-102D
Bloomington DSC line 24,488 injected with tTAV construct
Y-hid w1118/ hs-hid VDRC line 60,001
Ploen Wild Caught in Plön, Germany Isofemale line generated in the Reed group and grown for 10+ generations
in the lab.
White Eyed w1118/ hs-hid Cross between male Y-hid and female Ploen flies selecting w1118 individuals
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Differentially expressed gene analysis
A moderated t test [43] was used to compare tet-on vs tet-
off expression levels for each probe within each life stage
and strain only, ie. the differentially expressed genes were
all identified by comparing a single strain and life stage of
transgenic flies in two different states: with tetracycline and
without tetracycline. Therefore, any effects on transcrip-
tome detected could only be due to the dietary tetracycline
and not due to differences in genetic background. We used
Benjamin-Hofberg correction for multiple testing using the
limma package [43]. FDR thresholds at 1%, 5%, 10%, 15%
and 25% were tested and produced similar overall pattern
of gene expression differences, but 10% FDR was the lowest
FDR tested for which we obtained large enough numbers
of differentially expressed genes to enable analysis of GO cat-
egories and genome-wide positional effects and avoided
potential false positives such as differentially expressed genes
in non-tTAV strain (see Table S3 in Additional File 6).
Ensuring that we used a single probe per Ensembl
Gene ID in the dataset further reduced the complexity.
Multiple copies of identical probes with p values both
under and over the threshold of 0.05 (moderated t-test)
were removed completely. In cases where there were
multiple probes with multiple p values assigned to a sin-
gle Ensembl Gene ID, we retained only the probe with
the lowest p value.
Common gene sets diagrams, principal component
analysis, and genomic plots were generated using limma,
UpSetR [48] prcomp and Bioconductor [47] packages.
Sliding window analysis was run using a custom func-
tion. Plots and diagrams were made with ggplot2 [42].
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Additional file 1: Table S1. Gene ontology analysis of differentially
expressed genes in transgenic strains. (DOCX 27 kb)
Additional file 2: Table S2. Gene ontology analysis of 31 differentially
expressed genes shared among all transgenic strains in larvae. (DOCX 15 kb)
Additional file 3: Figure S3. Proportion of differentially expressed
genes (with vs without tetracycline) in 10-gene windows across genes
commonly expressed in all adult (A, n = 9538) and larvae (B, n = 7773)
strains. (DOCX 10589 kb)
Additional file 4: Figure S1. Principal component analysis for adults
and larvae from all strains. (DOCX 124 kb)
Additional file 5: Figure S2. Relative log expression plots for adults
and larvae from all heterozygous strains. (DOCX 1671 kb)
Additional file 6: Table S3. Number of differentially expressed genes at
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